Picture Kentro Design Corporate and Web Design Berlin 650x65px
Financing › Details

Alexion–AstraZeneca: investment, 202012– acquisition $39b with $13.4b in cash + $25.6b in ADSs Alexion shareholders will own 15% of combined firm


Period Period 2020-12-12
Organisations Money taker Alexion Pharmaceuticals Inc. (Nasdaq: ALXN)
  Group Alexion (Group)
  Money source AstraZeneca plc (LSE: AZN)
  Group AstraZeneca (Group)
Products Product DRUGS, ORPHAN
  Product 2 pharmaceutical
Document Source AstraZeneca plc. (12/12/20). "Press Release: AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development [Not for any jurisdicition where violation of relevant laws]".

Record changed: 2020-12-15


Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for Alexion (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81

» top